Home/Duopharma Biotech Bhd/Wan Amir-Jeffery Bin Wan Abdul Majid
WA

Wan Amir-Jeffery Bin Wan Abdul Majid

Group Chief Executive Officer

Duopharma Biotech Bhd

Duopharma Biotech Bhd Pipeline

DrugIndicationPhase
OmesecVarious therapeutic areas (generic)Marketed
PrelicaVarious therapeutic areas (generic)Marketed
Biosimilar for anemia in chronic renal failureAnemia associated with chronic renal failureMarketed (Halal certified)